CombiPhos Catalysts, Inc. operates as a catalytic technology based company worldwide. The company operates in three segments: Novel Homogeneous Catalysts developed from DuPont combinatorial catalysis technologies, Pharmaceutical Intermediates derived from novel cross-coupling reactions and homogeneous catalysis, and Deuterium Drug Discovery through patented various catalytic H/D exchanges and C-D cross-coupling reactions.
